Stock Market News

Biotech News

2 weeks Legend Biotech Corporation (LEGN) Q3 2024 Earnings Call TranscriptSeeking Alpha X

2 weeks Top Biotech Neurogene Crashes 44%, Wiping Out Its Sprint On A $200 Million DealInvestor's Business Daily X

2 weeks Bristol Myers Stock Trading Near 52-Week High: Time to Buy or Sell?Zacks X

2 weeks Tevogen Bio Partners with Microsoft Corporation (MSFT) to Leverage Advanced AI Tools for Biotech Research in HealthcareInsider Monkey X

2 weeks 1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or MoreThe Motley Fool X

2 weeks 2 Biotech Stocks You Can Buy Hand Over Fist This MonthThe Motley Fool X

2 weeks 5 Small Drug Stocks to Buy as Trump Gets Re-ElectedZacks X

2 weeks Biotech startup works on new regenerative drugsYouTube X

2 weeks Why Guardant Health Stock Blasted 13% Higher on ThursdayThe Motley Fool X

2 weeks Moderna’s stock pops after biotech ekes out a surprise profit, and revenue beats by a wide marginMarketWatch X

2 weeks Why TransMedics Stock Plunged in OctoberThe Motley Fool X

2 weeks Gilead’s third-quarter earnings beat by a wide margin, and biotech raises guidanceMarketWatch X

3 weeks Biotech Stocks Edge Higher. Could Trump 2.0 Mean More Innovation, Dealmaking?Investor's Business Daily X

3 weeks Intellia Therapeutics Just Notched Another Win. So Why Did Its Stock Fall 18% in 1 Day?The Motley Fool X

3 weeks What’s in Store for These 5 Drug & Biotech Stocks in Q3 Earnings?Zacks X

3 weeks Krystal Q3 Earnings and Sales Top Estimates, Vyjuvek Gains TractionZacks X

3 weeks Why Summit Therapeutics Stock Was a Winner TodayThe Motley Fool X

3 weeks Why Viking Therapeutics Stock Plummeted After Soaring TodayThe Motley Fool X

3 weeks Krystal Biotech, Inc. (KRYS) Q3 2024 Earnings Call TranscriptSeeking Alpha X

3 weeks Gilead Science to Report Q3 Earnings: What’s in the Cards?Zacks X

3 weeks This Beaten-Down Stock Could Soar by 354%, According to Wall StreetThe Motley Fool X

3 weeks Amgen: A Biotech Giant Offering Value And Growth In A Frothy MarketSeeking Alpha X

3 weeks Buffett Still Building This Stake, Plus Huge Insider Buy in Biotech IPO24/7 Wall St. X

3 weeks Is Recursion Pharmaceuticals a Millionaire-Maker Stock?The Motley Fool X

3 weeks ADMA Biologics, A Top 1% Stock, Skyrockets After Settling Its Accounting DebacleInvestor's Business Daily X

3 weeks Regeneron Takes A Ghastly Turn As High-Dose Eylea Lags And Biosimilars LoomInvestor's Business Daily X

3 weeks This High-Flying Stock Just Became a Better BuyThe Motley Fool X

3 weeks Why Guardant Health Stock Was the Picture of Health TodayThe Motley Fool X

4 weeks Short Interest in IO Biotech, Inc. (NASDAQ:IOBT) Declines By 12.7%MarketBeat X

4 weeks Harmony Bio, The No. 1 Biotech Stock, Surges On Its ‘High Quality’ BeatInvestor's Business Daily X

4 weeks Regeneron to Report Q3 Earnings: What’s in the Offing?Zacks X

4 weeks Should Bristol Myers Stock Be in Your Portfolio Pre-Q3 Earnings?Zacks X

4 weeks Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts?Zacks X

4 weeks Novo Holdings A S Has $3.52 Million Position in IO Biotech, Inc. (NASDAQ:IOBT)MarketBeat X

4 weeks Oncolytics Biotech Inc. (NASDAQ:ONCY) Sees Significant Increase in Short InterestMarketBeat X

4 weeks 3 Key Trends That Are Bullish for Recursion Pharmaceuticals StockThe Motley Fool X

4 weeks The Ultimate Biotech Stock to Buy With $50 Right NowThe Motley Fool X

4 weeks Legend Biotech Co. (NASDAQ:LEGN) Receives Consensus Recommendation of “Buy” from AnalystsMarketBeat X

4 weeks U.S. IPO Weekly Recap: Sizable Tech And Biotech IPOs Are Joined By A Flurry Of Small NamesSeeking Alpha X

1 month Why Intellia Therapeutics Stock Plummeted by 20% TodayThe Motley Fool X

1 month Why Viking Therapeutics Stock Soared by Nearly 21% on ThursdayThe Motley Fool X

1 month XBI: Biotech ETF Is A Must HaveSeeking Alpha X

1 month Zai Lab, A Top 6% Stock, Launched To A 16-Month High On Its ‘Impressive’ ResultsInvestor's Business Daily X

1 month Viking Therapeutics’ stock soars 18% as data on oral weight-loss drug loomsMarketWatch X

1 month 5 Biotech Stocks Likely to Outperform as Industry Prospects Look BrightZacks X

1 month What sector do you think will be the next bubble?Reddit X

1 month 1 Brand-New Big Reason to Buy This Biotech Stock Right NowThe Motley Fool X

1 month Recursion Pharmaceuticals (RXRX): A Promising Small-Cap in Biotech InnovationInsider Monkey X

1 month Viridian Therapeutics (VRDN): A Small-Cap Biotech with Promising Clinical ResultsInsider Monkey X

1 month Mirum Pharmaceuticals (MIRM): A Small-Cap Biotech with Strong Sales GrowthInsider Monkey X

< Newer News Older News >